A5011858857- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Policy and Management
- Patient-Provider Communication in Healthcare
- Spinal Cord Injury Research
- Healthcare cost, quality, practices
- Total Knee Arthroplasty Outcomes
- Reproductive Health and Contraception
- Reproductive Health and Technologies
- Patient Satisfaction in Healthcare
- Palliative Care and End-of-Life Issues
- Obstructive Sleep Apnea Research
- Primary Care and Health Outcomes
- Migraine and Headache Studies
- Elder Abuse and Neglect
- Delphi Technique in Research
- Global Health Care Issues
- Statistical Methods in Clinical Trials
- Cerebral Palsy and Movement Disorders
- Systemic Sclerosis and Related Diseases
- Disability Education and Employment
- Musculoskeletal Disorders and Rehabilitation
- Genomic variations and chromosomal abnormalities
- Cystic Fibrosis Research Advances
- Trigeminal Neuralgia and Treatments
- Economic and Financial Impacts of Cancer
University of Washington
2023-2024
Seattle University
2023-2024
University of South Australia
2023
University of Technology Sydney
2022-2023
Dalhousie University
2023
Research Canada
2017-2023
Centre for Health Evaluation and Outcome Sciences
2014-2023
St. Paul's Hospital
2014-2023
Center For Policy Research
2019-2023
University of California, Davis
2020-2023
The purpose of this study is to estimate the current lifetime economic burden traumatic spinal cord injury (tSCI) in Canada from a societal perspective, including both direct and indirect costs, using an incidence-based approach.Available resource use cost information for complete/incomplete tetraplegia paraplegia was applied estimated annual incidence tSCI, by severity, Canada.The per individual with tSCI ranges $1.5 million incomplete $3.0 complete tetraplegia. associated 1389 new persons...
While the rates of total knee arthroplasty (TKA) continue to rise worldwide, there are concerns about whether all surgeries appropriate. Guidelines for appropriateness suggest that patients should have realistic expectations (TKA), and patient their surgeon agree potential benefits outweigh harms. The objective this study is evaluate routinely collected pre- post-TKA patient-reported outcome measures (PROMs) could be integrated into a decision aid better inform these criteria. This...
Migraine is a prevalent neurologic disorder that affects women more than men. Examining health-related quality of life (HRQoL) by gender can aid decision makers in prioritizing future treatment and prevention programs. We aimed to quantify HRQoL different levels migraine disability gender.
Abstract Background When people who can use or benefit from research findings are engaged as partners on study teams, the quality and impact of better. These include patients/consumers clinicians do not identify researchers. They referred to “knowledge users”. This partnered approach is called integrated knowledge translation (IKT). We know little about users’ involvement in conduct systematic reviews. aimed evaluate team members’ degree meaningful engagement their perceptions having used an...
Economic evaluations commonly accompany trials of new treatments or interventions; however, regression methods and their corresponding advantages for the analysis cost-effectiveness data are not widely appreciated.To illustrate regression-based economic evaluation, we review a conducted by Canadian Cancer Trials Group's Committee on Analysis implement net benefit regression.Net offers simple option analyses person-level data. By placing evaluation in framework, techniques can facilitate...
There are analytic challenges involved with estimating the aggregate burden of multiple risk factors (RFs) in a population. We describe methodology to account for overlapping RFs some sub-populations, phenomenon that leads "double-counting" diseases and economic generated by those factors.Our method uses an efficient approach accurately analyze chronic disease across multifactorial system. In addition, it involves considering effect body weight as continuous or polytomous exposure ranges...
Background In 2014, a systematic review found large gaps in the quality of reporting measures used 86 published trials evaluating effectiveness patient decision aids (PtDAs). The purpose this study was to update that review. Methods We examined making 49 randomized controlled included 2014 and 2017 Cochrane Collaboration PtDAs. Data on development measures, reliability, validity, responsiveness, precision, interpretability, feasibility, acceptability were independently abstracted by 2 paired...
<h3>Background:</h3> Decision aids help patients make total joint arthroplasty decisions, but presurgical evaluation might influence the effects of a decision aid. We compared aid among considering knee at 2 surgical screening clinics with different processes. <h3>Methods:</h3> performed subgroup analysis randomized controlled trial. Patients were recruited from clinics: an academic clinic providing 20-minute physician consultations and community 45-minute physiotherapist/nurse education....
Objective. To understand the limitations with current patient-reported outcome measures (PROM) used to generate quality-adjusted life-years (QALY) in rheumatology, and set a research agenda. Methods. Two activities were undertaken. The first was scoping review of published studies that have PROM QALY rheumatology between 2011 2016. second an interactive “eyeball test” exercise at Outcome Measures Rheumatology 13 compared subdomains widely generic PROM, as identified through review,...
Abstract Rationale Total knee arthroplasty is a common surgical procedure but not appropriate for all patients with osteoarthritis. Patient decision aids (PtDAs) can promote shared making and enhance understanding expectations of procedures among patients, resulting in better discussions between healthcare providers about whether total the most option. Aims Objectives Evaluate impact an individualised PtDA osteoarthritis considering 1 year after baseline assessment. Methods Prospective,...
Background. There is increasing evidence highlighting the effectiveness of patient decision aids (PtDAs), but supporting their cost-effectiveness lacking. We consider patients with obstructive sleep apnea (OSA), in whom a PtDA may decrease nonadherence to treatment by empowering receive option that most congruent own values. Objective. To determine potential costs and benefits delivering moderate OSA. Methods. A Markov cohort decision-analytic model was developed for OSA, comparing usual...